Posts

The Anti Aging Backlash: Are We Optimising Our Health and Forgetting to Live?

Image
Supplements. Peptides. Protein-maxxing. Zone 2 training. Biological-age tests. Therapeutic plasma exchange. Off-label medications. Wearables tracking almost every measurable aspect of our biology. The modern longevity movement promises something extraordinary: the possibility of extending not just lifespan, but the years we remain healthy, independent and mentally sharp. Yet an important question is emerging. Are we becoming so preoccupied with extending life that we are forgetting how to live it? Longevity has grown into a major commercial opportunity, attracting pharmaceutical companies, biotechnology investors, wellness entrepreneurs, researchers and direct-to-consumer health businesses. Some developments are scientifically promising. Others remain experimental, while some commercial claims have moved far ahead of the available evidence. The growing backlash is therefore worth examining. Three books published in the past year capture a growing sentiment ...

Long-Term GLP-1 Treatment: Genetics, Nutrition, Muscle Preservation and Weight Maintenance

Image
Last updated: November 2026 | Evidence review GLP-1 medications have transformed the management of obesity and metabolic disease. Medicines such as semaglutide and tirzepatide can produce substantial weight loss, improve several cardiometabolic risk factors and, in appropriate patients, provide benefits that extend beyond the number on the weighing scale. However, achieving weight loss is only part of the treatment journey. Other important questions emerge as treatment progresses: Why do some people lose substantially more weight than others taking the same medication? Can genetics help explain differences in medication response and side effects? How can nutritional deficiencies and muscle loss be prevented? Should patients continue treatment indefinitely after reaching their target weight? Can a lower maintenance dose preserve weight-loss benefits? What happens when someone reduces, stops or changes their medication? These questions should not be considered separate...

The Peptide Knowledge Hub: Evidence, Benefits, Risks and Safety (2026 Guide)

Image
OneDayMD Research Team | Evidence and regulatory review: 16 November 2026 | Independent health research and education Peptides have become one of the most talked-about subjects in modern medicine, regenerative medicine, aesthetics, sports performance and longevity research. From GLP-1 medications for obesity and diabetes to BPC-157 for tissue repair, GHK-Cu for skin health and MOTS-c for metabolic research, interest in peptides is expanding rapidly. But an important question is often overlooked: what do we actually know about these substances, and how much of what is being marketed has been demonstrated in humans? Some peptide-based medicines have transformed clinical care and are supported by extensive randomised controlled trials. Other compounds have demonstrated interesting biological effects in laboratory experiments or animal models but have little or no reliable human evidence. The rapidly growing market has also created concerns about product authenticity, m...